ALLR (STOCKS)
Allarity Therapeutics, Inc. Common Stock
$1.180300
-0.089700 (-7.06%)
Prev close: $1.270000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Thomas H. Jensen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $18.82M
- Employees
- 7
- P/E (TTM)
- -1.60
- P/B (TTM)
- 2.08
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.19 | $-0.23 | +0.0446 | +19.01% |
|
Jun 2025 (Q2)
|
$-0.15 | $-0.21 | +0.0642 | +29.97% |
|
Sep 2024 (Q3)
|
$-7.71 | $-8.69 | +0.9804 | +11.28% |
|
Jun 2024 (Q2)
|
$-3.30 | $-8.78 | +5.4822 | +62.42% |
Financial Statements
| Revenues | $320.00K |
| Benefits Costs and Expenses | $11.55M |
| Costs And Expenses | $11.55M |
| Nonoperating Income/Loss | $1.37M |
| Operating Expenses | $12.93M |
| Research and Development | $6.60M |
| Other Operating Expenses | $6.32M |
| Operating Income/Loss | -$12.61M |
| Income/Loss From Continuing Operations After Tax | -$11.23M |
| Income/Loss From Continuing Operations Before Tax | -$11.23M |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$11.23M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.23M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.23M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.78 |
| Basic Average Shares | 14,378,942 |
| Assets | $18.26M |
| Current Assets | $17.93M |
| Prepaid Expenses | $2.11M |
| Other Current Assets | $15.82M |
| Noncurrent Assets | $330.00K |
| Fixed Assets | $330.00K |
| Liabilities | $8.43M |
| Current Liabilities | $8.43M |
| Accounts Payable | $4.28M |
| Other Current Liabilities | $4.15M |
| Noncurrent Liabilities | $0.00 |
| Equity | $9.83M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.83M |
| Liabilities And Equity | $18.26M |
| Net Cash Flow From Operating Activities | -$14.82M |
| Net Cash Flow From Operating Activities, Continuing | -$14.82M |
| Net Cash Flow From Investing Activities | -$8.00K |
| Net Cash Flow From Investing Activities, Continuing | -$8.00K |
| Net Cash Flow From Financing Activities | $10.65M |
| Net Cash Flow From Financing Activities, Continuing | $10.65M |
| Net Cash Flow | -$4.18M |
| Net Cash Flow, Continuing | -$4.18M |
| Comprehensive Income/Loss | -$11.90M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.90M |
| Other Comprehensive Income/Loss | -$11.90M |